Obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: The Rancho Bernardo study

Journal of Women's Health and Gender-Based Medicine

Volumn 8, Issue 10, 1999, Pages 1265-1272

  Jernström, Helena ^a,b   Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN; PROINSULIN; SOMATOMEDIN C;

ADULT; AGED; ANAMNESIS; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BODY WEIGHT; BREAST CANCER; BREAST CELL; CANCER RISK; CASE CONTROL STUDY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ESTROGEN THERAPY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; WEIGHT GAIN;

EID: 0033428262     PISSN: 15246094     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1.1999.8.1265     Document Type: Article

References (36)

1. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev 1993;15:110.
2. Key T, Pike M. The role of oestrogens and progestogens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24:29.
3. Magnusson C, Colditz G, Rosner B, Bergström R, Persson I. Association of family history and other risk factors with breast cancer risk. Cancer Causes Control 1998;9:259.
4. Barnes-Josiah D, Potter JD, Sellers TA, Himes JH. Early body size and subsequent weight gain as predictors of breast cancer incidence (Iowa, United States). Cancer Causes Control 1995;6:112.
5. Mannisto S, Pietinen P, Pyy M, Palmgren J, Eskelinen M, Uusitupa M. Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status. Int J Cancer 1996;68:8.
6. Kaaks R, Van Noord PA, Den Tonkelaar I, Peeters PJH, Riboli E, Grobbee DE. Breast-cancer incidence in relation to height, weight and body-fat distribution in the Dutch "DOM" cohort. Int J Cancer 1998;76:647.
7. Bruning PF, Bonfrer JM, van Noord PA, Hart AA, de Jong-Bakker M, Nooijen WJ. Insulin resistance and breast-cancer risk. Int J Cancer 1992;52:511.
8. Petrek JA, Peters M, Cirrincione C, Rhodes D, Bajorunas D. Is body fat topography a risk factor for breast cancer? Ann Intern Med 1993;118:356.
9. Underwood LE, van Wyk JJ. Normal and aberrant growth. In: Wilson J, Foster D, eds. Williams textbook of endocrinology, 8th ed. Philadelphia: Saunders, 1992:1079.
10. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15:48.
11. Bruning P, Van Doom J, Bonfrèr JMG, et al. Insulin-like growth factor-binding protein 3 is decreased in early-stage operable premenopausal breast cancer. Int J Cancer 1995;62:266.
12. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res 1990;50:7415.
13. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995;16:3.
14. Panno ML, Salerno M, Pezzi V, et al. Effect of oestradiol and insulin on the proliferative pattern and on oestrogen and progesterone receptor contents in MCF-7 cells. J Cancer Res Clin Oncol 1996;122:745.
15. Papa V, Reese C, Brunetti A, Vigneri R, Siiteri P, Goldfine I. Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells. Cancer Res 1990;50:7858.
16. Weissberger A, Ho K, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor-1 and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 1991;72:374.
17. Espeland MA, Hogan PE, Fineberg SE, et al. Effect of postmenopausal hormone therapy on glucose and insulin concentrations. Diabetes Care 1998;21:1589.
18. Daughaday WH, Mariz IK, Blethen SI. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab 1980;51:781.
19. Bowsher RR, Walney JD, Frank BH. A rapid and sensitive radioimmunoassay for the measurement of proinsulin in the human serum. Diabetes 1992;41:1048.
20. Morgan CR, Lazaro A. Immunoassay of insulin: Two antibody system. Plasma insulin levels in normal subdiabetic and diabetic rats. Diabetes 1963;12:115.
21. Pijl H, Meinders AE. Bodyweight range as an adverse effect of drug treatment. Mechanisms and management. Drug Safety 1996;14:329.
22. Cold S, Hansen S, Overvad K, Rose C. A woman's build and the risk of breast cancer. Eur J Cancer 1998; 34:1163.
23. Stoll A. Nutrition and breast cancer risk: Can an effect via insulin resistance be demonstrated? Breast Cancer Res Treat 1996;38:239.
24. Barrett-Connor E. The prevalence of diabetes mellitus in an adult community as determined by history or fasting hyperglycemia. Am J Epidemiol 1980;111:705.
25. Kazer R. Insulin resistance, insulin-like growth factor 1 and breast cancer: A hypothesis. Int J Cancer 1995;62:403.
26. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 1998;351:1393.
27. Rajaram S, Baylink DJ, Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and function. Endocrine Rev 1997; 18:801.
28. Ng EH, Ji CY, Tan PH, Lin V, Soo KC, Lee KO. Altered serum levels of insulin-like growth factor-binding proteins in breast cancer patients. Ann Surg Oncol 1998;5:194.
29. Collabortive Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047.
30. Hankinson SE, Willett WC, Manson JE, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995;87:1297.
31. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36.
32. Alexander FE, Roberts MM. The menopause and breast cancer. J Epidemiol Community Health 1987;41:94.
33. Jacobsen BK, Lund E. Level of education, use of oral contraceptives and reproductive factors: The Tromso Study. Int J Epidemiol 1990;19:967.
34. Mezzetti M, La Vecchia C, Decarli A, Boyle P, talamini R, Franceschi S. Population attributable risk for breast cancer: Diet, nutrition, and physical exercise. J Natl Cancer Inst 1998;90:389.
35. Palmer JR, Rosenberg L, Clarke EA, et al. Breast cancer and cigarette smoking: A hypothesis. Am J Epidemiol 1991;134:1.
36. Brunet JS, Ghadirian P, Rebbeck TR, et al. Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J Natl Cancer Inst 1998;90:761.